KADAYIFÇILAR, S. And İNAM, O. 2017. AFLIBERCEPT as FIRST LINE THERAPYFOR NEOVASCULAR TYPEAGE-RELATED MACULAR DEGENERATION: A REAL-LIFE STUDY. 17th EURETINA CONGRESS , (Barcelona, Spain).

KADAYIFÇILAR, S., & İNAM, O., (2017). AFLIBERCEPT as FIRST LINE THERAPYFOR NEOVASCULAR TYPEAGE-RELATED MACULAR DEGENERATION: A REAL-LIFE STUDY . 17th EURETINA CONGRESS, Barcelona, Spain

KADAYIFÇILAR, SİBEL, And ONUR İNAM. "AFLIBERCEPT as FIRST LINE THERAPYFOR NEOVASCULAR TYPEAGE-RELATED MACULAR DEGENERATION: A REAL-LIFE STUDY," 17th EURETINA CONGRESS, Barcelona, Spain, 2017

KADAYIFÇILAR, SİBEL And İNAM, ONUR. "AFLIBERCEPT as FIRST LINE THERAPYFOR NEOVASCULAR TYPEAGE-RELATED MACULAR DEGENERATION: A REAL-LIFE STUDY." 17th EURETINA CONGRESS , Barcelona, Spain, 2017

KADAYIFÇILAR, S. And İNAM, O. (2017) . "AFLIBERCEPT as FIRST LINE THERAPYFOR NEOVASCULAR TYPEAGE-RELATED MACULAR DEGENERATION: A REAL-LIFE STUDY." 17th EURETINA CONGRESS , Barcelona, Spain.

@conferencepaper{conferencepaper, author={SİBEL KADAYIFÇILAR And author={ONUR İNAM}, title={AFLIBERCEPT as FIRST LINE THERAPYFOR NEOVASCULAR TYPEAGE-RELATED MACULAR DEGENERATION: A REAL-LIFE STUDY}, congress name={17th EURETINA CONGRESS}, city={Barcelona}, country={Spain}, year={2017}}